NOT KNOWN DETAILS ABOUT BMS-986141

Investigators also glance to evaluate linvoseltamab in relapsed/refractory many myeloma as Portion of the section three LINKER-MM3 trial.Experimental: Dose expansion_sub-inhabitants 2_higher dose of niraparib MTDs and/or prospect RP2Ds for elimusertib made use of together with niraparib at the next fixed dose.MICU1-deficient in vitro styles display